[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,550,010
  • Shares Outstanding, K 29,688
  • Annual Sales, $ 427,540 K
  • Annual Income, $ -21,020 K
  • EBIT $ -66 M
  • EBITDA $ -41 M
  • 60-Month Beta 1.96
  • Price/Sales 3.91
  • Price/Cash Flow 24.55
  • Price/Book 6.57

Options Overview Details

View History
  • Implied Volatility 75.04% (+3.67%)
  • Historical Volatility 208.14%
  • IV Percentile 47%
  • IV Rank 26.86%
  • IV High 133.95% on 10/23/25
  • IV Low 53.41% on 08/28/25
  • Expected Move (DTE 5) 0.87 (1.66%)
  • Put/Call Vol Ratio 0.54
  • Today's Volume 1,269
  • Volume Avg (30-Day) 2,389
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 21,350
  • Open Int (30-Day) 19,132
  • Expected Range 51.34 to 53.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.19
  • Number of Estimates 1
  • High Estimate $-0.19
  • Low Estimate $-0.19
  • Prior Year $0.50
  • Growth Rate Est. (year over year) -138.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.21 +62.09%
on 05/06/26
57.15 -8.64%
on 06/04/26
+17.70 (+51.29%)
since 05/05/26
3-Month
32.21 +62.09%
on 05/06/26
95.38 -45.26%
on 03/09/26
-29.79 (-36.33%)
since 03/05/26
52-Week
32.21 +62.09%
on 05/06/26
170.87 -69.44%
on 12/02/25
-16.96 (-24.52%)
since 06/05/25

Most Recent Stories

More News
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK , June 7, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings...

WGS : 52.21 (-7.22%)
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

NEW YORK , June 6, 2026 /PRNewswire/ --

WGS : 52.21 (-7.22%)
Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026....

WGS : 52.21 (-7.22%)
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: ...

WGS : 52.21 (-7.22%)
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition - Hagens Berman

SAN FRANCISCO , June 5, 2026 /PRNewswire/ -- GeneDx Holdings ( NASDAQ: WGS ) faces a securities class action after the price of the company's stock cratered $33.42 (-49%) on May 5, 2026 in response...

WGS : 52.21 (-7.22%)
WGS INVESTOR ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead the GeneDx Class Action Lawsuit

SAN DIEGO , June 4, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May...

WGS : 52.21 (-7.22%)
Investor Notice: Robbins LLP Informs Investors of the GeneDx Holdings Corp. Class Action Lawsuit

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16,...

WGS : 52.21 (-7.22%)
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS

SAN FRANCISCO , June 4, 2026 /PRNewswire/ -- Investors in GeneDx Holdings Corp. ( NASDAQ: WGS ) saw the price of their shares tank $33.42 (-49%) on May 5, 2025 after the company announced a massive...

WGS : 52.21 (-7.22%)
DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Deadline on August 3, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx to Contact Him Directly to Discuss Their Options...

WGS : 52.21 (-7.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 59.50
2nd Resistance Point 57.89
1st Resistance Point 55.05
Last Price 52.21
1st Support Level 50.61
2nd Support Level 49.00
3rd Support Level 46.16

See More

52-Week High 170.87
Fibonacci 61.8% 117.90
Fibonacci 50% 101.54
Fibonacci 38.2% 85.18
Last Price 52.21
52-Week Low 32.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.